Markers of combined aerogenic exposure to metal oxides and transformed plasma proteomic profiles in children

View or download the full article: 
PDF icon health-risk-analysis-2023-1-13.pdf
UDC: 
57.044; 616.092
DOI: 
10.21668/health.risk/2023.1.13.eng
Authors: 

M.A. Zemlyanova1,2,3, N.V. Zaitseva1,4, Yu.V. Koldibekova1, E.V. Peskova1, N.I. Bulatova1, M.S. Stepankov1

Organization: 

1Federal Scientific Center for Medical and Preventive Health Risk Management Technologies, 82 Monastyrskaya Str., Perm, 614045, Russian Federation
2 Perm State University, 15 Bukireva Str., Perm, 614990, Russian Federation
3Perm National Research Polytechnic University, 29 Komsomolskii Ave., Perm, 614990, Russian Federation
4Russian Academy of Sciences, Medical Sciences Division (Preventive Medicine Section), 14 Leninskii Ave., Moscow, 119071, Russian Federation

Abstract: 

Changes in homeostatic balance of the body, primarily at the cellular-molecular level, are a relevant research object in fundamental and applied studies. They can be eligible indicators for predicting negative effects under exposure to chemical risk factors.

The aim of this study was to substantiate markers of a transformed plasma proteomic profile in children. These markers should have prognostic value and an evidence-based association with combined aerogenic exposure to metal oxides (copper and nickel oxides used as an example). We propose an innovative methodical approach based on plasma proteomic profiling that includes the following: identification of identical proteins and genes encoding their expression; quantification of indicators within the ‘identical protein – a chemical concentration in blood’ system; prediction of negative effects as per indicators of homeostasis destabilization at the cellular-molecular level under chronic aerogenic exposure to chemicals. The proposed algorithm was tested by comparing changed proteins and peptides identified in plasma proteomic profiles of children exposed simultaneously to nickel and copper oxides in ambient air in actual conditions and small rodents under experimental combined and isolated exposure to the analyzed chemicals in levels equal to real ones.

Long-term aerogenic exposure simultaneously to copper and nickel oxides was established to create elevated nickel and copper levels in blood of exposed children substantiated as markers of exposure. They were up to 2.4 times higher against the same indicators in unexposed children and reference levels as well. The results of field observations were verified by elevated levels of the same chemicals in blood under experimental modelling of an equivalent combined exposure performed on biological models. APOBEC1 complement factor (the А1CF gene) was substantiated as an identical proteomic marker based on plasma proteomic profiling in experimental and field investigations. It has an evidence-based association with markers of exposure (nickel and copper simultaneously identified in blood). Lower expression of this protein under persistent combined aerogenic exposure to nickel and copper oxides makes it possible to predict such a negative effect as modification of low density lipoproteins with further induction of atherosclerotic changes in vessels, the latter being a risk factor of cardiovascular diseases.

Keywords: 
proteomic markers, markers of exposure, children, biological model, the А1CF gene expression, prediction of negative effects
Zemlyanova M.A., Zaitseva N.V., Koldibekova Yu.V., Peskova E.V., Bulatova N.I., Stepankov M.S. Markers of combined aerogenic exposure to metal oxides and transformed plasma proteomic profiles in children. Health Risk Analysis, 2023, no. 1, pp. 137–146. DOI: 10.21668/health.risk/2023.1.13.eng
References: 
  1. Palcev M.A., Chemezov A.S., Linkova N.S., Drobintseva A.O., Polyakova V.O., Belushkina N.N., Kvetnoy I.M. Om-ics technology: the role and significance for personalized medicine. Molekulyarnaya meditsina, 2019, no. 4, pp. 3–8. DOI: 10.29296/24999490-2019-04-01 (in Russian).
  2. Kiku P.F., Gigaev D.S., Shiter N.S., Sabirova K.M., Mezentseva M.A. The concept of risk factors for the health of the population. Byulleten' fiziologii i patologii dykhaniya, 2016, no. 62, pp. 101–109. DOI: 10.12737/23260 (in Russian).
  3. Zhetisheva R.A., Kovaleva M.A., Kamenihina I.A., Kovalev L.I., Naumov V.G. The protein biomarkers search in atherosclerosis using proteomic technologies – as a promising area of science. Ateroskleroz i dislipidemii, 2020, vol. 39, no. 2, pp. 12–19. DOI: 10.34687/2219–8202.JAD.2020.02.0002 (in Russian).
  4. Davis A.P., Grondin C.J., Johnson R.J., Sciaky D., Wiegers J., Wiegers T.C., Mattingly C.J. Comparative Toxicogenomics Database (CTD): update 2021. Nucleic Acids Research, 2021, vol. 49, no. D1, pp. D1138–D1143. DOI: 10.1093/nar/gkaa891
  5. Davis A.P., Wiegers T.C., Wiegers J., Johnson R.J., Sciaky D., Grondin C.J., Mattingly C.J. Chemical-Induced Phenotypes at CTD Help Inform the Predisease State and Construct Adverse Outcome Pathways. Toxicological sciences: an official journal of the Society of Toxicology, 2018, vol. 165, no. 1, pp. 145–156. DOI: 10.1093/toxsci/kfy131
  6. Zaitseva N.V., Zemlianova M.A., Dolgikh O.V. Genomic, transcriptomic and proteomic technologies as a modern tool for health disorders diagnostics, associated with the impact of environmental factors. Gigiena i sanitariya, 2020, vol. 99, no. 1, pp. 6–12. DOI: 10.47470/0016-9900-2020-99-1-6-12 (in Russian).
  7. Dolgikh O.V., Dianova D.G., Kazakova O.A. Vanadium in the environment as a risk factor causing negative modification of cell death (scientific review). Health Risk Analysis, 2020, no. 4, pp. 156–169. DOI: 10.21668/health.risk/2020.4.18.eng
  8. Cunningham R.P., Porat-Shliom N. Liver Zonation – Revisiting Old Questions With New Technologies. Frontiers in physiology, 2021, no. 12, pp. 732929. DOI: 10.3389/fphys.2021.732929
  9. Eberhart T., Schönenberger M.J., Walter K.M., Charles K.N., Faust P.L., Kovacs W.J. Peroxisome-Deficiency and HIF-2α Signaling Are Negative Regulators of Ketohexokinase Expression. Frontiers in cell and developmental biology, 2020, vol. 566, no. 8. DOI: 10.3389/fcell.2020.00566
  10. Faizo N., Narasimhulu C.A., Forsman A., Yooseph S., Parthasarathy S. Peroxidized Linoleic Acid, 13-HPODE, Alters Gene Expression Profile in Intestinal Epithelial Cells. Foods (Basel, Switzerland), 2021, vol. 10, no. 2, pp. 314. DOI: 10.3390/foods10020314
  11. Hart J.E., Clarke I.J., Risbridger G.P., Ferneyhough B., Vega-Hernández M. Mysterious inhibitory cell regulator investigated and found likely to be secretogranin II related. Peer J., 2017, no. 5, pp. e3833. DOI: 10.7717/peerj.3833
  12. Chen X.S. Insights into the Structures and Multimeric Status of APOBEC Proteins Involved in Viral Restriction and Other Cellular Functions. Viruses, 2021, vol. 13, no. 3, pp. 497. DOI: 10.3390/v13030497
  13. Rosenberg B.R., Hamilton C.E., Mwangi M.M., Dewell S., Papavasiliou F.N. Transcriptomewide sequencing reveals numerous APOBEC1 mRNA-editing targets in transcript 3' UTRs. Nat. Struct. Mol. Biol., 2011, vol. 18, no. 2, pp. 230–236. DOI: 10.1038/nsmb.1975
  14. Chen Z., Eggerman T.L., Bocharov A.V., Baranova I.N., Vishnyakova T.G., Csako G., Patterson A.P. Hypermutation induced by APOBEC-1 overexpression can be eliminated. RNA (New York, N.Y.), 2010, vol. 16, no. 5, pp. 1040–1052. DOI: 10.1261/rna.1863010
  15. Lo C.C., Coschigano K.T. ApoB48 as an Efficient Regulator of Intestinal Lipid Transport. Front. Physiol., 2020, vol. 11, pp. 796. DOI: 10.3389/fphys.2020.00796
  16. Nikolaou K.C., Vatandaslar H., Meyer C., Schmid M.W., Tuschl T., Stoffel M. The RNA-Binding Protein A1CF Regulates Hepatic Fructose and Glycerol Metabolism via Alternative RNA Splicing. Cell reports, 2019, vol. 29, no. 2, pp. 283–300.e8. DOI: 10.1016/j.celrep.2019.08.100
  17. Song M.O., Li J., Freedman J.H. Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. Physiological genomics, 2009, vol. 38, no. 3, pp. 386–401. DOI: 10.1152/physiolgenomics.00083.2009
  18. Sutunkova M.P., Katsnelson B.A., Privalova L.I., Solovjeva S.N., Gurvich V.B., Minigalieva I.A., Klinova S.V., Bushueva T.V. [et al.]. Experimental assessment of the nanoparticles toxicity of nickel oxide in two sizes in the subchronic ex-periment. ZNiSO, 2018, vol. 309, no. 12, pp. 30–35 (in Russian).
  19. Dziedzic E.A., Tuzimek A., Gąsior J.S., Paleczny J., Junka A., Kwaśny M., Dąbrowski M., Jankowski P. Investigation on the Association of Copper and Copper-to-Zinc-Ratio in Hair with Acute Coronary Syndrome Occurrence and Its Risk Factors. Nutrients, 2022, vol. 14, no. 19, pp. 4107. DOI: 10.3390/nu14194107
  20. Marín-García J. Molecular Determinants of Atherosclerosis. Post-Genomic Cardiology, 2014, pp. 183–215. DOI: 10.1016/b978-0-12-404599-6.00006-8
  21. Sukhorukov V.N., Karagodin V.P., Orekhov A.N. Atherogenic modification of low-density lipoproteins. Biomeditsinskaya khimiya, 2016, vol. 62, no. 4, pp. 391–402. DOI: 10.18097/PBMC20166204391 (in Russian).
Received: 
17.12.2022
Approved: 
14.02.2023
Accepted for publication: 
21.03.2023

You are here

Home